Skip to main content
SpringerLink
Log in

Molecular Pharmacology of Hallucinogens

  • Chapter
Book cover Recent Advances in Biological Psychiatry

Abstract

There is as yet no satisfactory biological explanation for any of the major psychoses. However, the gap in knowledge is diminishing, and already there is a flourishing exchange of ideas and correlations between clinician and researcher. In fact, there is an ever increasing number of practising psychiatrists with active biological research interests.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ashcroft, G.W., Crawford, T.B.B., Eccleston, D., Sharman, D.F., MacDougall, E. J., Stanton, J.B., and Binns, J.K.: 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases, The Lancet 2:1049, 1966.

    Article  CAS  Google Scholar 

  2. Axelrod, J.: Metabolism of epinephrine and other sympathomimetic amines, Physiol. Rev. 39:751, 1959.

    PubMed  CAS  Google Scholar 

  3. Axelrod, J.: Enzymatic formation of psychotomimetic metabolites from normally occurring compounds. Science 134:343, 1961.

    Article  PubMed  CAS  Google Scholar 

  4. Baldessarini, R. J., and Kopin, I. J.: Assay of tissue levels of I-adenosyl-methionine, Anal. Biochem. 6:289, 1963.

    CAS  Google Scholar 

  5. Benington, F., Morin, R.D., and Clark, L.C. Jr.: 5-Methoxy-N,N-dimethyltryptamine, a possible endogenous psychotoxin, Ala. J. Med. Sci. 2:397, 1965.

    PubMed  CAS  Google Scholar 

  6. Beriet, H.H., Bull, C., Himwich, H.E., Kohl, H., Matsumoto, K., Pscheidt, G.R., Spaide, J., Tourlentes, T.T., and Valverde, J.M.: Endogenous metabolic factor in schizophrenic behavior. Science 144:311, 1964.

    Article  Google Scholar 

  7. Bovet, D., and Gatti, G. L.: Analysis of the action of the psychotropic drugs in a “lever-pressing avoidance” conditioning, in: Horvath, M., and Vinar, O., Psychopharmacological Methods, Pergamon Press, Oxford, 1963. p. 50.

    Google Scholar 

  8. Bovet, D., and Gatti, G.L.: Analysis of parameters of the action of psycholeptic and psychomi-metic drugs in a lever-pressing avoidance conditioning, in: Bradley, P.B., Hügel, F., and Hoch, P., Neuropsychopharmacology, Elsevier, Amsterdam, 1964, p. 514.

    Google Scholar 

  9. Bovet, D., and Gatti, G.L.: Pharmacology of conditioning, learning and retention, in: Proceedings of 2nd International Pharmacological Meeting, Prague, 1965, p. 75.

    Google Scholar 

  10. Bowers, M.B., and Freedman, D. X.: “Psychedelic” experiences in acute psychoses, Arch. Gen. Psychiat. 15:240, 1966.

    Article  PubMed  Google Scholar 

  11. Brune, G.G., and Himwich, H.E.: Indole metabolites in schizophrenic patients, Arch. Gen. Psychiat. 6:324, 1964.

    Article  Google Scholar 

  12. Brune, CG., and Himwich, H.E.: Effects of methionine loading on the behavior of schizophrenic patients, J. Nerv. Ment. Dis. 134:447, 1962.

    Article  PubMed  CAS  Google Scholar 

  13. Brune, C.G., and Himwich, H.E.: Biogenic amines and behavior in schizophrenic patients, in: Wortis, J. (ed.). Recent Advances in Biological Psychiatry, Plenum Press, New York, 1963, p. 144.

    Google Scholar 

  14. Clark, L.C., Jr., Benington, F., and Morin, R. D.: The effects of ring-methoxy groups on biological deamination of phenethylamines, J. Med. Chem. 8:353, 1965.

    Article  PubMed  CAS  Google Scholar 

  15. Clark, F.C., and Steele, B. J.: Some observations on the interaction of chlorpromazine and free operant avoidance bursts, Psychopharmacologia 4:221, 1963.

    Article  PubMed  CAS  Google Scholar 

  16. De Jong, H.H.: Experimental Catatonia, Williams and Wilkins, Baltimore, 1945.

    Google Scholar 

  17. Estes, W.K., and Skinner, B.F.: Some quantitative aspects of anxiety, J. Exptl. Psychol. 29:390, 1941.

    Article  Google Scholar 

  18. Ferster, C.B., and Skinner, B.F.: Schedules of Reinforcement, Appleton Century-Crofts, New York, 1957.

    Book  Google Scholar 

  19. Friedhoff, A. J., and Goldstein, M.: New developments in metabolism of mescaline and related amines, Ann. N.Y. Acad. Sci. 96:5, 1962.

    Article  PubMed  CAS  Google Scholar 

  20. Friedhoff, A. J., and Van Winkle, E.: Isolation and characterization of a compound from the urine of schizophrenics. Nature (London) 194:897, 1962.

    Article  CAS  Google Scholar 

  21. Gaddum, J.H.: Antagonism between lysergic acid diethylamide and 5-hydroxytryptamine, J. Physiol. 121:1, 1953.

    Google Scholar 

  22. Gessner, P.K., and Page, I.H.: Behavioural effects of 5-methoxy-N,N-dimethyltryptamine, other tryptamines, and L.S.D., Am. J. Physiol. 203:167, 1962.

    CAS  Google Scholar 

  23. Goldwurm, G. F., and Gualandri, E.: personal communication, 1966.

    Google Scholar 

  24. Greiner, A.C., and Nicholson, G. A.: Schizophrenia-melanosis: Cause or side-effect?, The Lancet 1:1165, 1965.

    Article  Google Scholar 

  25. Guttman, E., and Maclay, W.S.: Mescaline and depersonalization, J. Neurol. Psychopath. 16:193, 1936.

    Article  Google Scholar 

  26. Heath, Nesselhof, W. Jr., and Timmons, E.: D,L-methionine-D,L-sulphoximine effects in schizophrenic patients, Arch. Gen. Psychiat. 14:213, 1966.

    Article  PubMed  CAS  Google Scholar 

  27. Hollister, L.E., and Friedhoff, A. J.: Effects of 3,4-dimethoxyphenylethylamine in man, Nature (London) 210:1377, 1966.

    Article  CAS  Google Scholar 

  28. Holmstedt, B.: Gas-chromatographic analysis of some psychoactive indole bases, in: Himwich, H.E., Kety, S.S., and Smythies, J.R. (eds.), Amines and Schizophrenia, Pergamon Press, Atlantic City, N.J., 1967, p. 151.

    Google Scholar 

  29. Kety, S.S.: Proceedings of the 3rd Int. Neurochemical Symposium, Strasbourg, 1958, in: Folch-Pi, J., Chemical Pathology of the Nervous System, Pergamon Press, London, 1961, p. 709.

    Google Scholar 

  30. Key, B.J., and Marley, E.: Effect of some sympathomimetic amines on behaviour and electrocortical activity of chicken, Electroenceph. Clin. Neurophysiol. 14:90, 1962.

    Article  PubMed  CAS  Google Scholar 

  31. Lai, H., Ginocchio, S., and Skefner, A.: The effect of α -methyl-3,4-dihydroxyphenylalanine (methyl-DOPA) and α -methyl-meta-tyrosine (α-MMT) on amphetamine toxicity. Life Sciences 3:190, 1963.

    Google Scholar 

  32. Marley, E., and Morse, W.H.: Operant conditioning in the newly hatched chicken, J. Exptl. Anal. Behav. 9:95, 1966.

    Article  CAS  Google Scholar 

  33. Mclsaac, W.M.: A biochemical concept of mental disease, Post-Grad. Med. 30:111, 1961.

    Google Scholar 

  34. Moore, K.E.: The role of endogenous norepinephrine in the toxicity of d-amphetamine in aggregated mice, J. Pharmacol. Exptl. Therap. 144:45, 1964.

    CAS  Google Scholar 

  35. Noteboom, L.: Experimental catatonia by means of derivatives of mescaline and adrenaline, Proc. Acad. Sci. (Amsterdam) 37:562, 1934.

    CAS  Google Scholar 

  36. Osmond, H., and Smythies, J.R.: Schizophrenia. Anew approach, J. Ment. Sci. 98:309, 1952.

    PubMed  CAS  Google Scholar 

  37. Park, L.C., Baldessarini, R. J., and Kety, S.S.: Methionine effects on chronic schizophrenics. Arch. Gen. Psychiat. 12:346, 1965.

    Article  PubMed  CAS  Google Scholar 

  38. Peretz, D., Smythies, J. R., and Gibson, W.C.: A new hallucinogen. Trimethoxy-phenyliso-propylamine, J. Ment. Sci. 101:317, 1955.

    PubMed  CAS  Google Scholar 

  39. Pollin, W., Cardon, P.V., and Kety, S.S.: Effects of amino acid feedings in schizophrenic patients treated with iproniazid, Science 133:104, 1961.

    Article  PubMed  CAS  Google Scholar 

  40. Quinton, R.M., and Halliwell, W.: Effects of α-methyl DOPA and DOPA on the amphetamine excitatory response in reserpinized rats, Nature (London) 200:178, 1963.

    Article  CAS  Google Scholar 

  41. Rosenberg, D.E., Isbell, H., and Miner, E.J.: Comparison of a placebo, N-dimethyltryp-tamine, and 6-hydroxy-N-dimethyltryptamine in man, Psychopharmacologia 4:39, 1963.

    Article  PubMed  CAS  Google Scholar 

  42. Shulgin, A. T.: Psychotomimetic amphetamines: Methoxy 3,4-dialkoxyamphetamines, Ex-perientia 20:366, 1964.

    Article  CAS  Google Scholar 

  43. Shulgin, A. T.: 3-Methoxy-4,5-methylenedioxyamphetamine, a new psychotomimetic agent, Nature (London) 201:1120. 1964.

    Article  CAS  Google Scholar 

  44. Sidman, M.: Avoidance conditioning with brief shock and no exteroceptive warning signal, Science 118:157, 1953.

    Article  PubMed  CAS  Google Scholar 

  45. Slotta, K. H., and Muller, J.: On the catabolism of mescaline and mescaline-like substances in the organism, Hoppe-Seyl. Z. 238:14, 1936.

    Article  CAS  Google Scholar 

  46. Smythies, J.R., and Levy, C.K.: The comparative psychopharmacology of some mescaline analogues, J. Ment. Sci. 106:531, 1960.

    PubMed  CAS  Google Scholar 

  47. Smythies, J. R., and Sykes, E.A.: The effect of mescaline upon the conditioned avoidance response in the rat, Psychopharmacologia 6:163, 1964.

    Article  PubMed  CAS  Google Scholar 

  48. Snyder, S.H., and Merril, C.R.: A quantum-chemical correlate of hallucinogenesis, in: Himwich, H.E., Kety, S.S., and Smythies, J.R. (eds.), Amines and Schizophrenia, Pergamon Press, Atlantic City, N, J., 1967, p. 229.

    Google Scholar 

  49. Steiner, J.E., and Sulman, F.G.: Simultaneous studies of blood sugar, serotonin metabolism, and electroencephalograms of the conscious rabbit after the administration of mescaline and psilocybin, Harokeach Haivri 9:498, 1963.

    CAS  Google Scholar 

  50. Stockings, G.T.: A clinical study of the mescaline psychosis with special reference to the mechanism of the genesis of schizophrenia and other psychotic states, J. Ment. Sci. 86:29, 1940.

    Google Scholar 

  51. Szara, S.: The comparison of the psychotic effect of tryptamine derivatives with the effects of mescaline and LSD-25 in self-experiments, in: Garatani, S., and Ghetti, V. (eds.), Psychotropic Drugs, Elsevier, Amsterdam, 1957, p. 460.

    Google Scholar 

  52. Taborsky, R.G., Delvigs, P., and Page, I.H.: 6-Hydroxylation: Effect on the psychotropic potency of tryptamines, Science 153:1018, 1966.

    Article  PubMed  CAS  Google Scholar 

  53. Westermann, E.O.: Metabolic factors controlling duration of drug action, in: Brodie, B.B., et al. (eds.), 1st Int. Pharm. Meeting, Pergamon Press, 1961.

    Google Scholar 

  54. Wikler, A.: The Relation of Psychiatry to Pharmacology, Williams and Wilkens, Baltimore, 1957.

    Google Scholar 

  55. Wilkinson, S.: 5-Methoxy-N-methyltryptamine: A new indole alkaloid from Phalaris arnun-dinacea, J. Chem. Soc. (London), 1958, p. 2078.

    Google Scholar 

Download references

Authors
  1. V. S. Johnston Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. J. Bradley Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Downstate Medical College, State University of New York, Brooklyn, New York, USA

    Joseph Wortis M.D. (Associate Clinical Professor of Psychiatry) (Associate Clinical Professor of Psychiatry)

Rights and permissions

Reprints and permissions

Copyright information

© 1968 Springer Science+Business Media New York

About this chapter

Cite this chapter

Johnston, V.S., Bradley, R.J. (1968). Molecular Pharmacology of Hallucinogens. In: Wortis, J. (eds) Recent Advances in Biological Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-9072-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-9072-5_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-9074-9

  • Online ISBN: 978-1-4684-9072-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation